Characterization of vB_SauM-fRuSau02, a Twort-Like Bacteriophage Isolated from a Therapeutic Phage Cocktail

Katarzyna Leskinen1, Henni Tuomala2,3, Anu Wicklund4,5

  • 1Department of Bacteriology and Immunology, Medicum, Research Programs Unit, Immunobiology Research Program, University of Helsinki, Helsinki 00290, Finland. katarzyna.leskinen@helsinki.fi.

Viruses
|September 15, 2017
PubMed

Insights

Bacteriophage fRuSau02 shows promise as a phage therapy agent against Staphylococcus aureus infections. This research characterizes its genome and demonstrates its effectiveness against clinical S. aureus strains, offering an alternative to antibiotics.

Area of Science:

  • Microbiology
  • Virology
  • Biotechnology

Background:

  • Staphylococcus aureus is a significant cause of human and animal infections, including hospital-acquired infections.
  • Increasing antibiotic resistance necessitates alternative therapeutic strategies.
  • Bacteriophages, particularly polyvalent myoviruses, are promising candidates for phage therapy.

Purpose of the Study:

  • To characterize the bacteriophage vB_SauM-fRuSau02 (fRuSau02) isolated from a commercial phage cocktail.
  • To evaluate the host range and potential of fRuSau02 as a therapeutic agent against Staphylococcus aureus.

Main Methods:

  • Genomic analysis of bacteriophage fRuSau02.
  • Identification of structural and virion-associated proteins using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • Host range testing against various Staphylococcus strains, including clinical isolates from humans and pigs.

Main Results:

  • fRuSau02 possesses a large genome (148,464 bp) and belongs to the Twortlikevirus genus.
  • 78 structural and virion-associated proteins were identified.
  • The phage demonstrated sensitivity against clinical Staphylococcus aureus strains and some coagulase-negative staphylococci, with varying efficacy against pig strains.

Conclusions:

  • fRuSau02 is a well-characterized bacteriophage with potential as a phage therapy agent.
  • It offers a viable alternative to antibiotic treatment for Staphylococcus aureus infections.
  • Further research into its application as a therapeutic agent is warranted.

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.1K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.4K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.2K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.9K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.9K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
642